Stauffer Chemical Company

Other

Robert C Nutter

Patricia A Okubara

Lucy C Panganiban

Dorothy A Pierce

A wound injector apparatus is described. The wound injector includes a clotting factor, an expandable material, a thermal agent, a chamber, and a nozzle. At least one chamber houses the clotting factor, the expandable factor and the thermal agent. Additionally, at least one nozzle is configured to discharge at least one of the clotting factor, the expandable material, and the thermal agent.

Wound injector apparatus

Recombinant plasmids adopted for transformation of prokaryotic and eukaryotic hosts having an insertion site for at least one DNA fragment are provided. In a preferred embodiment, nucleotide sequences coding for methotrexate-resistant dehydrofolate reductase and a nucleotide sequence, a portion thereof coding for a promoter, are ligated into the insertion site.

Hybrid plasmid with marker

Plasmids derived from Corynebacterium glutamicum, particularly pRN3.1, of suitable size, about 3.1 kilobases in length and weight about 2.0.times.10.sup.6 daltons, and having a limited number of restriction sites therein, suitable as vehicles for genetic engineering of Corynebacterium.

Growing community of inventors

El Cerrito, CA, United States of America

Robert C Nutter